Literature DB >> 2054455

What is the psychiatric significance of bilateral basal ganglia mineralization?

H Förstl1, B Krumm, S Eden, K Kohlmeyer.   

Abstract

One percent (143) of patients who underwent cranial computed tomography at the Central Institute of Mental Health during the last 10 years had bilateral basal ganglia mineralization (BGM). The relationship of this finding to the psychiatric disorders in the group was evaluated by statistical comparison with a group of patients without BGM (control group). The odds ratios for affective disorders and for organic brain syndromes with affective or paranoid symptoms showed a mild, but statistically significant, increase in patients with BGM. There was no evidence of an increased proportion of dementia, schizophrenia, or alcoholism in those with BGM. Those with BGM had a higher mean age and significantly more cortical atrophy and ventricular enlargement than did patients without. These confounding variables contributed to clinical differences between the BGM and the control groups.

Entities:  

Mesh:

Year:  1991        PMID: 2054455     DOI: 10.1016/0006-3223(91)90201-v

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  5 in total

1.  GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome.

Authors:  Zi-Yang Zhu; Qiao-Li Zhou; Shi-Ning Ni; Wei Gu
Journal:  World J Pediatr       Date:  2014-08-15       Impact factor: 2.764

2.  Neurological disorders in 166 patients with basal ganglia calcification: a statistical evaluation.

Authors:  H Förstl; B Krumm; S Eden; K Kohlmeyer
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

3.  Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification.

Authors:  Sandy Chan Hsu; Renee L Sears; Roberta R Lemos; Beatriz Quintáns; Alden Huang; Elizabeth Spiteri; Lisette Nevarez; Catherine Mamah; Mayana Zatz; Kerrie D Pierce; Janice M Fullerton; John C Adair; Jon E Berner; Matthew Bower; Henry Brodaty; Olga Carmona; Valerija Dobricić; Brent L Fogel; Daniel García-Estevez; Jill Goldman; John L Goudreau; Suellen Hopfer; Milena Janković; Serge Jaumà; Joanna C Jen; Suppachok Kirdlarp; Joerg Klepper; Vladimir Kostić; Anthony E Lang; Agnès Linglart; Melissa K Maisenbacher; Bala V Manyam; Pietro Mazzoni; Zofia Miedzybrodzka; Witoon Mitarnun; Philip B Mitchell; Jennifer Mueller; Ivana Novaković; Martin Paucar; Henry Paulson; Sheila A Simpson; Per Svenningsson; Paul Tuite; Jerrold Vitek; Suppachok Wetchaphanphesat; Charles Williams; Michele Yang; Peter R Schofield; João R M de Oliveira; María-Jesús Sobrido; Daniel H Geschwind; Giovanni Coppola
Journal:  Neurogenetics       Date:  2013-01-20       Impact factor: 2.660

4.  SLC20A2 and THAP1 deletion in familial basal ganglia calcification with dystonia.

Authors:  Matt Baker; Audrey J Strongosky; Monica Y Sanchez-Contreras; Shan Yang; Will Ferguson; Donald B Calne; Susan Calne; A Jon Stoessl; Judith E Allanson; Daniel F Broderick; Michael L Hutton; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Neurogenetics       Date:  2013-10-18       Impact factor: 2.660

5.  Fahr's disease and psychiatric syndromes: A case series.

Authors:  Deepak Ghormode; Uma Maheshwari; Natasha Kate; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.